Skip to main content

Mosull del Campo, Raquel

Institutions of which they are part

Administration and Management
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Mosull del Campo, Raquel

Institutions of which they are part

Administration and Management
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

ERN-EuroBloodNet (European Reference Network on Rare Hematological Diseases)

IP: M Mar Mañu Pereira
Collaborators: Raquel Mosull del Campo
Funding agency: EUROPEAN COMMISSION
Funding: 1569581.5
Reference: EUROBLOODNET-ERN_EU4H2023
Duration: 01/10/2023 - 30/09/2027

ERICA - European Rare dIsease research Coordination and support Action

IP: M Mar Mañu Pereira
Collaborators: Claire Diot, Raquel Mosull del Campo
Funding agency: EUROPEAN COMMISSION
Funding: 105250
Reference: ERICA_H2020-SC1-BHC-2020
Duration: 01/03/2021 - 28/02/2025

Related news

"Generation of a bank of surgical orthotopic PDX (patient-derived xenografts) models within the framework of a personalized medicine program in pediatric cancer" was the awarded work, of the Childhood Cancer and Hematological Diseases Group of VHIR.

A study, co-led by Vall d’Hebron, has analysed the evolution of clinical trials with children and adolescents with cancer over the last 15 years, with the aim of optimising efficacy and defining lines for further progress.

The research team has shown that inhibiting the TRIB3 protein slows the growth of rhabdomyosarcoma and improves survival in animal models.

Related professionals

Patricia García Ortega

Patricia García Ortega

Research technician
Read more
Patricia González Ruiz

Patricia González Ruiz

Administration and Management
Childhood Cancer and Blood Disorders
Read more
Helena Genestal Vicente

Helena Genestal Vicente

Read more
Francesca Imbastari

Francesca Imbastari

Administration and Management
Liver Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.